EUDA Health Holdings regained compliance with Nasdaq's listing requirements after meeting market value criteria for ten consecutive days.
Quiver AI Summary
EUDA Health Holdings Limited, a Singapore-based non-invasive healthcare provider focused on Singapore, Malaysia, and China, received a notice from Nasdaq in April 2026 for failing to maintain a minimum market value of $35 million. However, the company regained compliance after its market value exceeded this threshold for ten consecutive business days from May 13 to May 27, 2026. EUDA aims to lead in non-invasive and preventive healthcare, particularly in the longevity sector, addressing the needs of an aging population in the region. The press release also includes forward-looking statements regarding the company's growth and business strategies, emphasizing the risks and uncertainties that may affect future performance.
Potential Positives
- The Company has regained compliance with the Nasdaq Minimum Market Value of Listed Securities requirement after demonstrating a market value of $35 million or greater for ten consecutive business days.
- This compliance restores the Company's listing status on the Nasdaq Capital Market, which is crucial for maintaining investor confidence and market visibility.
- The press release highlights the Company’s strategic focus on the fast-growing longevity sector, positioning it as a proactive leader in non-invasive healthcare in Asia.
- EUDA is addressing the healthcare needs of a significant demographic by focusing on aging populations, indicating strong market potential and relevance in its service offerings.
Potential Negatives
- Received a written notice from Nasdaq due to failure to maintain a Minimum Market Value of Listed Securities for 32 consecutive business days, which indicates potential financial instability.
- Initial failure to comply with Nasdaq listing requirements could impact investor confidence and perceived legitimacy of the company.
FAQ
What is the recent compliance update for EUDA Health Holdings?
EUDA Health Holdings regained compliance with Nasdaq's minimum market value requirement after exceeding $35 million for ten consecutive days.
Which markets does EUDA Health Holdings operate in?
EUDA is focused on non-invasive healthcare services in Singapore, Malaysia, and China.
What is EUDA's mission in the healthcare sector?
EUDA aims to transform healthcare by providing innovative, preventive solutions for the rapidly aging population in Asia.
What strategic focus areas are highlighted by EUDA Health Holdings?
EUDA is strategically focused on the fast-growing longevity sector and aims to lead in proactive healthcare.
How does EUDA plan to address regional healthcare needs?
EUDA plans to address healthcare needs through science-backed solutions tailored to the demographic shifts affecting 1.8 billion people.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$EUDA Hedge Fund Activity
We have seen 0 institutional investors add shares of $EUDA stock to their portfolio, and 5 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CITADEL ADVISORS LLC removed 2,232 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $5,155
- JANE STREET GROUP, LLC removed 1,284 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $12,718
- GEODE CAPITAL MANAGEMENT, LLC removed 1,033 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $10,231
- UBS GROUP AG removed 36 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $356
- SBI SECURITIES CO., LTD. removed 1 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $9
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Full Release
Singapore, June 01, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” and the “Company”), a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia and China, received a written notice (the “MVLS Notice”) from Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) on April 23, 2026, indicating that the Company had failed to maintain a Minimum Market Value of Listed Securities (“MVLS”) of $35 million over the last 32 consecutive business days as required by the Nasdaq Listing Rule 5550(b)(2).
On May 28, 2026, the Company received a written notice from Nasdaq stating that the Company’s Market Value of Listed Securities has been $35 million or greater for ten consecutive business days from May 13 to May 27, 2026, and therefore the Company has regained compliance with the MVLS requirement for continued listing on the Nasdaq Capital Market.
About EUDA Health Holdings Limited
EUDA Health Holdings Limited (NASDAQ: EUDA) is a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia and China. The Company aims to become a market leader in non-invasive and preventive healthcare, with a strategic focus on the fast-growing longevity sector. Our mission is to address the evolving healthcare needs of over approximately 1.8 billion people across the region which are experiencing significant demographic shifts as more than approximately 30% of the population ages rapidly. EUDA believes that by offering innovative, accessible, and science-backed health solutions, it is positioned to lead the transformation of regional healthcare from reactive medical treatment to proactive, longevity-focused care. EUDA also runs a Singapore-based property management business.
Forward-Looking Statements
Certain statements in this press release that are not historical facts constitute “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Any statements that refer to expectations or other characterizations of future events, circumstances or results are forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. The factors may include, but not be limited to, factors related to the Company’s anticipated growth strategies, future business development, ability to develop new products, expand to other related industries or markets, and other information detailed from time to time in the filings and future filings with the United States Securities and Exchange Commission. The views expressed are those of management and are based on currently available information. Estimates and projections contained herein have been prepared by management and involve significant elements of subjective judgment and analysis and are based on certain assumptions. No representation nor warranty, expressed or implied, is made as to the accuracy or completeness of the information contained in this document, and nothing contained herein is, or shall be relied upon, as a promise or representation, whether as to the past or the future. You are cautioned not to place undue reliance on these forward-looking statements.
This press release is intended solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy the Company’s stock. This press release is based upon information available to the public, as well as other information from sources which management believes to be reliable, but is not guaranteed by the Company as being accurate nor does it purport to be complete. Opinions expressed herein are those of management as of the date of publication and are subject to change without notice. Except for ongoing obligations of the Company to disclose material information under the federal securities laws, the Company does not undertake any obligation to release any revisions to any forward-looking statements, to report events or to report the occurrence of unanticipated events.
For investor and media inquiries, please contact:
Christensen Advisory
Christian Arnell
Phone: +852 2117 0861
Email:
[email protected]